Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner

CW Wanderley, DF Colon, JPM Luiz, FF Oliveira… - Cancer research, 2018 - AACR
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

[PDF][PDF] Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colón, JPM Luiz, FF Oliveira… - academia.edu
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colón, JPM Luiz, FF Oliveira… - Cancer …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Paclitaxel is an antineoplastic agent widely
used to treat several solid tumor types. The primary mechanism of action of paclitaxel is …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colon, JPM Luiz, FF Oliveira… - Cancer …, 2018 - bv.fapesp.br
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colón, JPM Luiz… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

[引用][C] Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1-profile in a TLR4-dependent manner

CW Wanderley, DF Colon, JPM Luiz, FF Oliveira… - Cancer …, 2018 - repositorio.usp.br
ReP USP - Detalhe do registro: Paclitaxel reduces tumor growth by reprogramming tumor-associated
macrophages to an M1- profile in a TLR4-dependent manner Home About USP Schools …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW WANDERLEY, DF COLON, JPM LUIZ… - 2018 - observatorio.fm.usp.br
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.

CW Wanderley, DF Colón, JPM Luiz, FF Oliveira… - Cancer …, 2018 - europepmc.org
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colon, JPM Luiz, FF Oliveira… - Cancer …, 2018 - bv.fapesp.br
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …

[PDF][PDF] Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner

CW Wanderley, DF Colón, JPM Luiz, FF Oliveira… - academia.edu
Paclitaxel is an antineoplastic agent widely used to treat several solid tumor types. The
primary mechanism of action of paclitaxel is based on microtubule stabilization inducing cell …